Insights

GLP-1 Market Update: Oral Drugs, New Formulations, Pipeline Activity, and Pricing Shifts 

Learn More

International Drug Sourcing Is Under Scrutiny. What Employers Should Understand Before Adopting It 

Learn More

Direct-to-Consumer (DTC) Prescription Drug Programs 

Learn More

Q1 2026 Drug Updates: New FDA Approvals, Generics, and Biosimilars to Watch 

Learn More

What Accurate PBM Modeling Really Takes — And Why Clients Deserve More Than a Dashboard 

Learn More

Department of Labor Proposes New PBM Fee Disclosure Requirements for Self-Insured Health Plans 

Learn More

The Audit That Pays for Itself: Why Reviewing Your PBM’s Performance Isn’t Optional  

Learn More

Filter Insights:

Join our newsletter to stay up to date on market trends.

By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.

Latest Insights

The Multimillion-Dollar Question Behind Cell and Gene Therapies for Plan Sponsors 

OnPoint-Light-Dark 2

A Navion Video Series

Welcome to On Point with Navion. In five minutes or less, we’ll break down what’s happening in pharmacy, what it means for your groups, and what to do next. No fluff, just what you need to know every month.

GET STARTED

Experience Navion in action with a savings analysis!

Our custom Rx savings analysis delivers a side by-side assessment to ensure your groups have a single source of truth to choose the PBM option that’s right for them.